Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group
根据IMDC风险标准，评估伊匹木单抗和纳武利尤单抗作为晚期肾细胞癌一线治疗的真实世界疗效和毒性——GUARDIANS研究组开展的一项多中心回顾性分析
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70267
Dinkel, Hendrik; Materna, Linus; Stelmach, Ramona; Zschäbitz, Stefanie; Neuberger, Stephanie; Aydogdu, Can D; Casuscelli, Jozefina; Egenolf, Timo; Silberg, Matteo; Steinestel, Julie; Strauss, Arne; Kirchhoff, Florian; Ahrens, Marit; Paffenholz, Pia; Cathomas, Richard; Özdemir, Berna C; Gossler, Christopher; Ivanyi, Philipp; Rehlinghaus, Marc; Hilser, Thomas; Grünwald, Viktor; Schlack, Katrin
